Literature DB >> 21686850

Acute generalised exanthematous pustulosis (AGEP) after cefotaxime use.

Amel Chaabane1, Karim Aouam, Khaled Harrathi, Najib Ben Yahia, Elyes Gassab, Leila Njim, Naceur A Boughattas.   

Abstract

A case of acute generalised exanthematous pustulosis (AGEP) after cefotaxime use confirmed by a positive patch test is reported. A 30-year-old woman received cefotaxime, fosfomycin and ciprofloxacin for sinusitis. At 12 days after drug initiation, she developed an extending pustular erythaema associated with fever. Laboratory investigations showed marked leukocytosis. Her blood chemistry was normal. The histological examination showed parakeratosis, spongiosis and non-follicular intra epidermal pustules consistent with AGEP. All medications were withdrawn. The symptoms resolved within 11 days after cefotaxime discontinuation. Patch tests were positive to cefotaxime after 48 h, while ciprofloxacin and fosfomycin yielded negative findings. Based on the Naranjo algorithm, it is probable that the AGEP reaction was due to cefotaxime. To our knowledge, this is the first reported case of AGEP associated to positive cefotaxime patch testing.

Entities:  

Year:  2009        PMID: 21686850      PMCID: PMC3029672          DOI: 10.1136/bcr.06.2008.0343

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

Review 1.  Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern.

Authors:  A Sidoroff; S Halevy; J N Bavinck; L Vaillant; J C Roujeau
Journal:  J Cutan Pathol       Date:  2001-03       Impact factor: 1.587

2.  Acute generalized exanthematous pustulosis due to diltiazem: confirmation by patch testing.

Authors:  J M Vicente-Calleja; A Aguirre; N Landa; V Crespo; R González-Pérez; J L Díaz-Pérez
Journal:  Br J Dermatol       Date:  1997-11       Impact factor: 9.302

3.  T-cell involvement in drug-induced acute generalized exanthematous pustulosis.

Authors:  M Britschgi; U C Steiner; S Schmid; J P Depta; G Senti; A Bircher; C Burkhart; N Yawalkar; W J Pichler
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 4.  Acute generalized exanthematous pustulosis.

Authors:  C Beylot; M S Doutre; M Beylot-Barry
Journal:  Semin Cutan Med Surg       Date:  1996-12

5.  Cross-comparison of patch test and lymphocyte proliferation responses in patients with a history of acute generalized exanthematous pustulosis.

Authors:  Michael Girardi; Karynne O Duncan; Robert E Tigelaar; Suguru Imaeda; Kalman L Watsky; Jennifer M McNiff
Journal:  Am J Dermatopathol       Date:  2005-08       Impact factor: 1.533

6.  Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  P Wolkenstein; O Chosidow; M L Fléchet; O Robbiola; M Paul; L Dumé; J Revuz; J C Roujeau
Journal:  Contact Dermatitis       Date:  1996-10       Impact factor: 6.600

Review 7.  Delayed drug hypersensitivity reactions.

Authors:  Werner J Pichler
Journal:  Ann Intern Med       Date:  2003-10-21       Impact factor: 25.391

8.  [Acute generalized exanthematic pustuloses (four cases) (author's transl)].

Authors:  C Beylot; P Bioulac; M S Doutre
Journal:  Ann Dermatol Venereol       Date:  1980 Jan-Feb       Impact factor: 0.777

9.  A case of recurrent acute generalized exanthematous pustulosis due to beta-lactam antibiotics: a case report.

Authors:  V Mysore; A Ghuloom
Journal:  J Dermatolog Treat       Date:  2003-01       Impact factor: 3.359

10.  Acute generalized exanthematous pustulosis associated with pseudoephedrine.

Authors:  M A Padial; J Alvarez-Ferreira; B Tapia; R Blanco; C Mañas; M Blanca; T Bellón
Journal:  Br J Dermatol       Date:  2004-01       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.